The page is the record's research on the issuer — no analyst, no rating, no view. # Passage BIO, Inc. (NASDAQ: PASG) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Passage BIO, Inc., listed on NASDAQ under ticker PASG, with ISIN US7027122099. The LEI is not on the record, as no GLEIF record carries the exact legal name in jurisdiction US-DE. The security type is Corporate, the segment is not on the record, the sector is 2836 Biological Products, (No Diagnostic Substances), and the jurisdiction is United States, Delaware. The issuer is listed and not halted. ## The disclosure read The record holds 48 filings across 30 filing days in the window 2025-11-08 to 2026-11-08. The filings are 13 directors_dealings, 12 regulatory_filing, 7 results, 6 prospectus, 3 ad_hoc, 3 agm_egm, 3 corporate_news and 1 director_change. The median gap between filing days is 8 days. The latest filing is dated 2026-11-06 and is of type director_change, 2 days before the record date. The NASDAQ exchange median is 6.0 days cadence, 52 filings and 5.0 days latency across 4359 issuers. The sector median is 5.5 days cadence, 65.5 filings and 4.0 days latency across 176 issuers. ## Auditor The auditor of record is KPMG LLP, located in Philadelphia, PA. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted. ## Orderability The outcome is not determinable, because the chapter's orderability section carries no client categories and the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage The issuer's investor-relations page names 6 research houses: Canaccord Genuity, Chardan, Cowen, Guggenheim Securities, Oppenheimer and Wedbush. ## Open research No openly published research notes were found on the record. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The record holds sealed years 2021, 2022, 2023, 2024, 2025 and 2026 for the issuer. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 9 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001787297.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/PASG (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/1787297/000110465926022549/pasg-20251231x10k.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://www.passagebio.com/investors-and-news/stock-information/default.aspx (coverage) - https://mcp.us-cm-kg.ai/record/NASDAQ/PASG (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/PASG · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp